Inogen Inc. Files Definitive Proxy Statement

TL;DR

<b>Inogen Inc. has filed its Definitive Proxy Statement for the period ending June 5, 2024.</b>

AI Summary

Inogen Inc (INGN) filed a Proxy Statement (DEF 14A) with the SEC on April 18, 2024. Inogen Inc. filed a Definitive Proxy Statement (DEF 14A) on April 18, 2024. The filing covers the period ending June 5, 2024. The company's principal executive offices are located at 859 Ward Drive, Goleta, CA 93111. Inogen Inc. is incorporated in Delaware. The Standard Industrial Classification code is 3842 for Orthopedic, Prosthetic & Surgical Appliances & Supplies.

Why It Matters

For investors and stakeholders tracking Inogen Inc, this filing contains several important signals. This filing provides crucial information regarding executive compensation, stock awards, and other governance matters for Inogen Inc. shareholders. Shareholders can review details on unvested equity, forfeited awards, and changes in award values for key executives, which may influence voting decisions.

Risk Assessment

Risk Level: — Inogen Inc shows moderate risk based on this filing. The filing is a routine DEF 14A, indicating standard corporate governance disclosures rather than immediate financial or operational news.

Analyst Insight

Review the executive compensation details and stock award information to understand potential impacts on shareholder value and company performance.

Key Numbers

• 2024-04-18 — Filing Date (DEF 14A filing date)
• 2024-06-05 — Reporting Period End Date (DEF 14A reporting period)
• 0001294133 — Central Index Key (Inogen Inc. CIK)
• 3842 — SIC Code (Orthopedic, Prosthetic & Surgical Appliances & Supplies)

Key Players & Entities

• Inogen Inc. (company) — FILER
• 0000950170-24-045541 (other) — ACCESSION NUMBER
• 20240418 (date) — FILED AS OF DATE
• 20240605 (date) — CONFORMED PERIOD OF REPORT
• 0001294133 (company) — CENTRAL INDEX KEY
• 3842 (other) — STANDARD INDUSTRIAL CLASSIFICATION
• DE (other) — STATE OF INCORPORATION
• 859 WARD DRIVE (address) — BUSINESS ADDRESS

FAQ

Industry Context

Inogen Inc. operates in the medical device sector, specifically focusing on respiratory products. The company's classification falls under Orthopedic, Prosthetic & Surgical Appliances & Supplies.

Regulatory Implications

The filing is a DEF 14A, which is a standard SEC filing for publicly traded companies to provide information to shareholders regarding annual meetings, director elections, and executive compensation.

What Investors Should Do

1. Review the detailed executive compensation tables for key personnel.
2. Analyze stock option awards and unvested equity for potential performance indicators.
3. Understand the voting matters presented to shareholders for the upcoming annual meeting.

Key Dates

• 2024-04-18: Filing Date — Filing of Definitive Proxy Statement
• 2024-06-05: Reporting Period End — Period covered by the proxy statement

Year-Over-Year Comparison

This is a DEF 14A filing, which is a routine disclosure. No direct comparison to a prior filing's specific financial or operational metrics is available in this excerpt.

Filing Documents

• ingn-20240418.htm (DEF 14A) — 2306KB
• img253252620_0.jpg (GRAPHIC) — 19KB
• img253252620_1.jpg (GRAPHIC) — 230KB
• img253252620_2.jpg (GRAPHIC) — 4KB
• img253252620_3.jpg (GRAPHIC) — 166KB
• img253252620_4.jpg (GRAPHIC) — 176KB
• img253252620_5.jpg (GRAPHIC) — 175KB
• img253252620_6.jpg (GRAPHIC) — 750KB
• img253252620_7.jpg (GRAPHIC) — 528KB
• 0000950170-24-045541.txt (&nbsp;) — 8584KB
• ingn-20240418.xsd (EX-101.SCH) — 30KB
• ingn-20240418_htm.xml (XML) — 465KB

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 43 - i - Compensation Discussion and Analysis 43 Executive Summary 44

Executive Compensation Philosophy and Program Design

Executive Compensation Philosophy and Program Design 48 Governance of Executive Compensation Program 50

Executive Compensation Elements and Corporate Performance Measure

Executive Compensation Elements and Corporate Performance Measure 52 Other Compensation Policies and Practices 61 Accounting Considerations 62 Compensation Committee Report 63 Compensation Risk Assessment 63 2023 Summary Compensation Table 64 Grants of Plan-Based Awards in 2023 66 Outstanding Equity Awards at 2023 Fiscal Year-End 67 Option Exercises and Stock Awards Vesting During Fiscal 2023 68 Potential Payments Upon Termination or Upon Change in Control 68 CEO Pay Ratio Disclosure Rule 71 Equity Compensation Plan Information 74

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 76 RELATED PERSON TRANSACTIONS 78 OTHER MATTERS 79 Section 16(a) Beneficial Ownership Reporting Compliance 79 Available Information 79 Company Website 79 PROPOSALS OF STOCKHOLDERS FOR 2024 ANNUAL MEETING 80 APPENDIX A - UNAUDITED RECONCILIATION FROM GAAP TO NON-GAAP 82 APPENDIX B - AMENDED & RESTATED 2023 EQUITY INCENTIVE PLAN 83 - ii - INOGEN, INC. 859 Ward Drive Goleta, California 93111 PROXY STATEMENT FOR 2024 ANNUAL MEETING OF STOCKHOLDERS To Be Held Virtually on June 5, 2024 at 10:00 a.m. Pacific Time This proxy statement and the accompanying form of proxy are furnished in connection with the solicitation of proxies by our Board of Directors (the "Board") of Inogen, Inc. ("Inogen" or the "Company") for use at our 2024 Annual Meeting of Stockholders, and any postponements, adjournments or continuations thereof (the "Annual Meeting"). The Annual Meeting will be held virtually via live webcast on the Internet at www.virtualshareholdermeeting.com/INGN2024 on Wednesday, June 5, 2024 at 10:00 a.m. Pacific Time in a virtual meeting format only. You will not be able to attend the Annual Meeting physically in person. The live webcast of the Annual Meeting can be accessed by stockholders on the day of the meeting at www.virtualshareholdermeeting.com/INGN2024. If you have difficulty accessing the virtual meeting during the check-in or meeting time, a technical assistance phone number will be made available on the virtual meeting registration page 15 minutes prior to the start time of the meeting. On or about April 18, 2024, we expect to mail to our stockholders a Notice of Internet Availability of Proxy Materials (the "Notice") containing instructions on how to access our proxy statement for our Annual Meeting and our annual report to stockholders ("Annual Report"). Information contained on, or that can be accessed through, our website is not intended to be inc

View Full Filing

View this DEF 14A filing on SEC EDGAR